Citigroup Raises MKS (NASDAQ:MKSI) Price Target to $430.00

MKS (NASDAQ:MKSI) had its price objective upped by stock analysts at Citigroup from $425.00 to $430.00 in a note issued to investors on Friday,Benzinga reports. The brokerage presently has a “buy” rating on the scientific and technical instruments company’s stock. Citigroup’s price target points to a potential upside of 40.99% from the company’s current price.

Several other research analysts have also weighed in on MKSI. Deutsche Bank Aktiengesellschaft set a $360.00 price target on MKS in a research report on Friday, July 31st. Morgan Stanley lifted their target price on MKS from $374.00 to $442.00 and gave the company an “overweight” rating in a research note on Monday, July 6th. TD Cowen reiterated a “buy” rating on shares of MKS in a report on Thursday, May 7th. KeyCorp increased their price target on shares of MKS from $360.00 to $475.00 and gave the stock an “overweight” rating in a research report on Monday, June 29th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of MKS in a report on Friday, July 17th. One investment analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $385.00.

MKS Trading Up 4.7%

MKS stock traded up $13.68 during midday trading on Friday, reaching $304.99. The stock had a trading volume of 1,224,043 shares, compared to its average volume of 1,410,718. MKS has a twelve month low of $97.30 and a twelve month high of $447.62. The company has a debt-to-equity ratio of 0.94, a current ratio of 1.11 and a quick ratio of 0.70. The firm has a market cap of $20.60 billion, a price-to-earnings ratio of 48.64, a PEG ratio of 0.84 and a beta of 1.98. The firm’s fifty day simple moving average is $348.18 and its two-hundred day simple moving average is $289.00.

MKS (NASDAQ:MKSI) last announced its earnings results on Wednesday, August 5th. The scientific and technical instruments company reported $3.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.91 by $0.39. The company had revenue of $1.25 billion for the quarter, compared to the consensus estimate of $1.20 billion. MKS had a net margin of 10.15% and a return on equity of 25.35%. The company’s revenue was up 28.3% on a year-over-year basis. During the same period in the previous year, the business earned $1.77 EPS. MKS has set its Q3 2026 guidance at 3.270-3.890 EPS. Equities analysts anticipate that MKS will post 11.81 EPS for the current fiscal year.

Insider Buying and Selling

In related news, Director Gerald G. Colella sold 20,000 shares of the business’s stock in a transaction that occurred on Wednesday, May 27th. The stock was sold at an average price of $333.40, for a total value of $6,668,000.00. Following the completion of the sale, the director owned 20,017 shares of the company’s stock, valued at approximately $6,673,667.80. The trade was a 49.98% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO John Tseng-Chung Lee sold 10,000 shares of the stock in a transaction that occurred on Friday, May 22nd. The stock was sold at an average price of $315.48, for a total value of $3,154,800.00. Following the completion of the transaction, the chief executive officer owned 144,696 shares in the company, valued at $45,648,694.08. This represents a 6.46% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 54,406 shares of company stock worth $17,577,866. Insiders own 0.57% of the company’s stock.

Institutional Trading of MKS

Several large investors have recently added to or reduced their stakes in MKSI. Allied Private Wealth LLC acquired a new position in shares of MKS during the 2nd quarter worth $33,000. Clearstead Trust LLC bought a new stake in MKS in the second quarter worth $36,000. Carolina Wealth Advisors LLC boosted its holdings in MKS by 47.5% in the second quarter. Carolina Wealth Advisors LLC now owns 87 shares of the scientific and technical instruments company’s stock worth $39,000 after purchasing an additional 28 shares in the last quarter. Bell Investment Advisors Inc acquired a new position in MKS during the second quarter worth $47,000. Finally, Global Retirement Partners LLC increased its position in MKS by 560.0% during the fourth quarter. Global Retirement Partners LLC now owns 165 shares of the scientific and technical instruments company’s stock worth $26,000 after buying an additional 140 shares during the last quarter. 99.79% of the stock is owned by institutional investors.

MKS News Roundup

Here are the key news stories impacting MKS this week:

• Positive Sentiment: Quarterly results exceeded expectations. MKS reported second-quarter revenue of approximately $1.25 billion, up 28.3% year over year and above the $1.20 billion consensus estimate. Adjusted EPS was $3.30, topping expectations near $2.91-$2.94 and rising sharply from $1.77 a year earlier. MKSI Q2 Earnings Beat Estimates, Revenues Increase Year Over Year
• Positive Sentiment: Management issued upbeat third-quarter guidance. MKS forecast EPS of $3.27-$3.89 and revenue of $1.3-$1.4 billion, both above Wall Street’s prior expectations. The outlook reflects broad end-market growth and stronger operating leverage. MKS Surpasses Q2 Earnings and Revenue Estimates
• Positive Sentiment: AI demand is improving future visibility. MKS is ramping semiconductor and advanced-packaging capacity to meet AI-driven demand, with management citing better visibility into 2027. MKSI Q2 Earnings Call Highlights AI-Driven Capacity Ramp
• Positive Sentiment: Analysts raised valuation targets. JPMorgan increased its target to $380 and maintained an Overweight rating; Wells Fargo raised its target to $325 while keeping an Equal Weight rating. Needham previously raised its target to $390 and maintained a Buy rating. Brokerages’ overall recommendation is Moderate Buy.
• Neutral Sentiment: Near-term profitability remains a consideration. The capacity expansion supporting AI growth is creating some margin pressure, which could limit upside if execution or demand weakens.
• Negative Sentiment: Insider selling is a cautionary signal. Reported insider activity over the past six months showed 40 sales and no purchases, including sales by senior executives. This does not necessarily indicate deteriorating fundamentals but may temper investor enthusiasm.

MKS Company Profile

MKS Instruments, Inc (NASDAQ: MKSI) designs, manufactures and markets technology solutions that enable advanced processes in a variety of high‐technology and industrial markets. The company’s core offerings include vacuum and gas delivery systems, pressure and flow measurement instruments, optical metrology tools, photonics subsystems and critical components for manufacturing processes. These products support the precise control and monitoring needs of semiconductor, industrial manufacturing, life and health sciences, and research applications.

The company’s product portfolio features mass flow controllers, pressure transducers, vacuum gauges, gas purity monitors, laser-based metrology systems and photonic devices such as lasers and detectors.